Lynette Wright MSW

Lynette has worked at the Addictions, Drug & Alcohol Institute (ADAI) beginning in February 2010.   Her work with the Clinical Trail Network of the National Institute on Drug Abuse includes several areas of study: women with PTSD, liver toxicity of opioid users taking Suboxone, the effectiveness of the Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders, Cocaine Use Reduction With Buprenorphine (CURB), Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X-BOT), Opioid Use Disorder in the Emergency Department (ED-HEALTH), Implementation Survey of PrEP and Opioid Use Related Services in STI Clinics and MSM-Centered Community Based Organizations (CBOs), Peer Intervention to Link Overdose Survivors to Treatment (PILOT) and the use of injectable buprenorphine to reduce use for those with methamphetamine use disorder (MURB).

In addition, she has worked on CTN platform studies that include REMAS-CA, a culturally adapted, gender specific pilot intervention for African American and Hispanic men to reduce HIV risk behaviors and, the BEST Study: Maximizing the Patient-Counselor Relationship to Reduce Sexual Risk Behavior.  She has worked to review written and electronic data to ensure procedure adherence according to protocols, devised tracking and communications systems with participating research sites, assisted with writing materials for use in implementing studies, been responsible for hiring and oversight of study staff and developed relationship with participating sites/agencies to support problem solving and guidance.